In a preclinical study, a durable response was produced in immune-competent mice with the administration of AMG510, resulting in the infiltration of tumors by CD8+ T cells and the development of a pro-inflammatory tumor microenvironment [56]. The gene discussed is CD8A; the disease is neoplasm.